Restylane Defyne is intended to augment the volume of facial tissues. It is recommended to be used for correction of severe wrinkles, or tear troughs to redefine the shape of the lips, cheeks or tear troughs.

Depending on the area to be treated and the tissue support, the product should be injected in the mid to deep dermis, submucosal layer of the lips, subcutis or supraperiostic zone.

Lidocaine is added to the formulation to diminish the pain resulting from the injection during the treatment

Composition:-

• Cross-linked hyaluronic acid 20 mg/mL
• Lidocaine hydrochloride 3 mg/mL
• Phosphate buffered saline pH 7 qs ad 1 mL

Indication: Cheeks

Suitable needles (27G x ½” Ultra thin wall) are supplied with the syringe in the blister pack. As an alternative, a blunt thin walled cannula with a recommended size of 27G can be used.

(Formerly Emervel Deep)

We provide Galderma (U.K.) Limited with certain information on who has purchased their products through this website for consumer service/support and safety purposes. A copy of Galderma’s Privacy Notice explaining how your data will be collected, used, and disclosed by Galderma can be found here https://tinyurl.com/galdermaprivacy

Adverse events should be reported

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

For Ireland, suspected adverse events can be reported via HPRA Pharmacovigilance, www.hpra.ie

Adverse events should also be reported to Galderma (UK) Ltd.

E-mail: Medinfo.uk@galderma.com Tel: +44 (0) 300 3035674